MC
AMGN icon

Moors & Cabot’s Amgen AMGN Stock Holding History

Moors & Cabot’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-600
Closed -$5.46K – 919
2023
Q4 		$5.46K Buy
+600
New +$163K ﹤0.01% 830
2020
Q1 		– Sell
-500
Closed -$9K – 596
2019
Q4 		$9K Buy
+500
New +$110K ﹤0.01% 605

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Moors & Cabot's AMGN Position: Q1 2026 in Review

Moors & Cabot reduced its Amgen (AMGN) stake by 2.6% in Q1 2026, selling an estimated $141K and leaving 15,025 shares worth $5.29M. The position accounts for 0.23% of the portfolio, ranked #95.

Moors & Cabot first reported a position in AMGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $7.4M in Q4 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Moors & Cabot held 15,025 shares of Amgen worth $5.29M as of Q1 2026.
  • Moors & Cabot sold 395 Amgen shares in Q1 2026, an estimated $141K.
  • Amgen made up 0.23% of Moors & Cabot's portfolio in Q1 2026, its #95 holding.
  • Moors & Cabot first reported a position in Amgen in Q1 2014 and has held it in 49 quarters since.
  • Moors & Cabot's Amgen position peaked at $7.4M in Q4 2019.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.